Eurordis are interested in patient experiences of drugs that have not been licensed for specific conditions, ie drugs like Rituximab/Rituxan and Anti D which are licensed drugs but have not been specifically licensed for use in ITP. We have been asked by Eurordis to ask that anyone who has been treated for their ITP with Rituximab/Rituxan or Anti D please consider completing a short survey to help them with their research. As someone who was treated for my ITP with Rituximab I completed the survey myself and it took me just over five minutes. The last date for completion of the survey is April 15th. Just follow the link..... surveymonkey.com/s/off_labe...
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.